8-K 1 crhmedical_8k.htm FORM 8-K  

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Rule 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

November 19, 2019

 

 

CRH MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

 

British Columbia, Canada 001-37542 Not Applicable

 (State or other jurisdiction

of incorporation)

 

(Commission

File Number)

(IRS Employer

Identification No.)

     

Suite 578 - 999 Canada Place, World Trade Center, Vancouver,

British Columbia, Canada

V6C 3E1
(Address of principal executive offices) (Zip Code)
   
(604) 633-1440
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name of former address, if changed since last report)

 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

   
 
 

ITEM 7.01 REGULATION FD DISCLOSURE

On November 19, 2019, CRH Medical Corporation issued a press release regarding the majority purchase of Triad Sedation Associates, a gastroenterology anesthesia practice located in North Carolina. A copy of the press release is being furnished herewith as Exhibit 99.1.

 

The information provided under this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

 

Exhibit No.   Description
99.1   Press Release issued by CRH Medical Corporation on November 19, 2019

 

 

 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

             
   

CRH MEDICAL CORPORATION

    (Registrant)
     
Date: November 19, 2019   By:  

/s/ Richard Bear

   

Name:

Title:

 

Richard Bear

Chief Financial Officer